25 - 31 August 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Ibudilast slows atrophy in progressive MS
Ibudilast slowed loss of brain tissue (atrophy) by about half compared to placebo in a phase II study in people with primary or secondary progressive MS. The study wasn't looking at any effect on symptoms or on slowing progression and a future research will need to look at this
MS Trust link: Ibudilast
Tecfidera and Gilenya compared
The effectiveness of Tecfidera or Gilenya was similar according to a real life study of people at two US clinics. People on the treatments had fewer relapses than the rate seen in research trials. More people chose to stop Tecfidera than Gilenya and tended to stop sooner.
Source: MS News Today
MS Trust link: MS Decisions - a guide to drugs for relapsing MS
Managing functional illness
A neurologist writes managing someone exhibiting symptoms of MS but whose tests indicate that they didn't have the condition.
Source: Daily Telegraph
MS in the Media
17 May 2019
- Statin has potential as SPMS drug
- EastEnders MS storyline
My Vespa adventure for the MS Trust
13 May 2019
For his next fundraising adventure, our supporter Nick Jolly will be riding 2,500 miles to Hungary on his Vespa scooter. He tells us about the inspiration behind his challenge.
"When you lose something, it makes you appreciate what you have"
13 May 2019
Danielle MacGillivray stars in our new film, Danielle. Here she tells us about her MS diagnosis, why she wanted to share her story in the film and learning to "appreciate the little things" every single day.